Come up with a name for your new list and we'll add to it:
EpiVax raised a round of funding on July 30, 2012. Investors include
National Heart Lung and Blood Institute.
EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …